The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / 10 Clinical Insights from Rheumatology Top Secrets & Pearls

10 Clinical Insights from Rheumatology Top Secrets & Pearls

December 7, 2020 • By Vanessa Caceres

  • Tweet
  • Email
Print-Friendly Version / Save PDF

ACR CONVERGENCE 2020—Attendees at Rheumatology Top Secrets and Pearls gained new insights into the diagnosis and treatment of inflammatory arthritis, inflammatory eye conditions, giant cell arteritis and many other rheumatic diseases.

You Might Also Like
  • Tocilizumab Is Effective to Treat GCA
  • New Insights into the Management of Giant Cell Arteritis
  • Trial Data Reveals the Limitations of Steroids in Giant Cell Arteritis Therapy
Also By This Author
  • Rheumatology Care: Access & Affordability

Presenters Jason R. Kolfenbach, MD, associate professor of medicine and ophthalmology and director of the Rheumatology Fellowship Program, University of Colorado School of Medicine, Colorado Springs; and John H. Stone, MD, MPH, professor of medicine, Harvard Medical School, and the Edward A. Fox Chair in Medicine, Massachusetts General Hospital, Boston, shared pearl after pearl to expand attendees’ clinical knowledge. Here are 10 clinical insights from their presentations.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Inflammatory Arthritis
1. Record a disease activity score in all patients with inflammatory arthritis, Dr. Kolfenbach advised. “We know that treat to target is better than gestalt,” he said. Even when associations between the patient global assessment and the physician global assessment break down, the score can still provide valuable information. Additionally, when patients have a global assessment that is larger than the physician global assessment by more than 2 cm, this could indicate higher rates of fibromyalgia, osteoarthritis and depression, Dr. Kolfenbach said.

2. Let your patient history and physical exam lead the way. Results from labs and X-rays should be extras that assist with your diagnosis and not the main guiding factors, Dr. Kolfenbach said. The exam and history are the real determiners of a diagnosis. Additionally, the rheumatologist’s hands are the most powerful tool to diagnose rheumatoid arthritis (RA).

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

3. Examine the feet. The feet can provide clues into RA, Dr. Kolfenbach noted. Look for anterior displacement of the fat pad, posterior tibial dysfunction or a cock-up deformity of the toes. The presence of these conditions can lead to such recommendations as better shoes, orthotics, physical therapy or a referral to a podiatrist if needed, he said.

Inflammatory Eye Disease
4. Know the difference between conjunctivitis, episcleritis and scleritis, Dr. Kolfenbach advised. If eye signs and symptoms are part of a particular condition, rheumatologists should know some basic differentials. For scleritis, 50% is usually related to connective tissue disease, such as RA or granulomatosis with polyangiitis. Less commonly, it could indicate ankylosing spondylitis or gout. On exam, scleritis will not blanch with phenylephrine and may be violaceous. For episcleritis, only about 10% is associated with connective tissue disease, such as atopy or advanced gout. In an eye exam, the eye will be sectoral and have a lack of palpebral conjunctivitis, he said.

Pages: 1 2 3 | Single Page

Filed Under: ACR Convergence, Conditions, Meeting Reports, Vasculitis Tagged With: ACR Convergence 2020, Diagnosis, GCA, giant cell arteritis (GCA), Inflammatory Eye Disease, Vasculitis

You Might Also Like:
  • Tocilizumab Is Effective to Treat GCA
  • New Insights into the Management of Giant Cell Arteritis
  • Trial Data Reveals the Limitations of Steroids in Giant Cell Arteritis Therapy
  • Efficacy of Tocilizumab Monotherapy After Ultra-Short Glucocorticoid Administration in GCA

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)